DK3436007T3 - Beta-amino-pateamin-A-derivater og fremgangsmåder til behandling af kronisk lymfocytisk leukæmi - Google Patents
Beta-amino-pateamin-A-derivater og fremgangsmåder til behandling af kronisk lymfocytisk leukæmi Download PDFInfo
- Publication number
- DK3436007T3 DK3436007T3 DK17776804.1T DK17776804T DK3436007T3 DK 3436007 T3 DK3436007 T3 DK 3436007T3 DK 17776804 T DK17776804 T DK 17776804T DK 3436007 T3 DK3436007 T3 DK 3436007T3
- Authority
- DK
- Denmark
- Prior art keywords
- pateamine
- beta
- derivatives
- amino
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662316299P | 2016-03-31 | 2016-03-31 | |
| PCT/US2017/025448 WO2017173313A1 (en) | 2016-03-31 | 2017-03-31 | Beta-amimo pateamine a derivatives and methods for treating chronic lymphocytic leukemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3436007T3 true DK3436007T3 (da) | 2022-03-14 |
Family
ID=59965302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17776804.1T DK3436007T3 (da) | 2016-03-31 | 2017-03-31 | Beta-amino-pateamin-A-derivater og fremgangsmåder til behandling af kronisk lymfocytisk leukæmi |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10889596B2 (https=) |
| EP (1) | EP3436007B1 (https=) |
| JP (1) | JP6993348B2 (https=) |
| CA (1) | CA3018192C (https=) |
| DK (1) | DK3436007T3 (https=) |
| ES (1) | ES2913210T3 (https=) |
| WO (1) | WO2017173313A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024254195A1 (en) * | 2023-06-06 | 2024-12-12 | Baylor University | Methods for treating pancreatic cancer with a combination of des-methyl pateamine a and a class 1 hdac inhibitor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0647645A1 (en) | 1993-10-12 | 1995-04-12 | Pharma Mar, S.A. | Novel antitumoral and antiviral compound |
| US7737134B2 (en) | 2002-03-13 | 2010-06-15 | The Texas A & M University System | Anticancer agents and use |
| US7230021B2 (en) | 2002-03-13 | 2007-06-12 | The Texas A&M University System | Potent, simplified derivatives of pateamine A |
| US20130053994A1 (en) * | 2011-08-31 | 2013-02-28 | General Electric Company | Method and apparatus for monitoring radiopharmaceutical processing |
| WO2013152299A2 (en) * | 2012-04-06 | 2013-10-10 | University Of North Carolina At Chapel Hill | Inhibitors of eif4a and derivatives of pateamine a with antiviral activity and use |
-
2017
- 2017-03-31 DK DK17776804.1T patent/DK3436007T3/da active
- 2017-03-31 ES ES17776804T patent/ES2913210T3/es active Active
- 2017-03-31 EP EP17776804.1A patent/EP3436007B1/en active Active
- 2017-03-31 US US16/090,528 patent/US10889596B2/en active Active
- 2017-03-31 WO PCT/US2017/025448 patent/WO2017173313A1/en not_active Ceased
- 2017-03-31 JP JP2018551799A patent/JP6993348B2/ja active Active
- 2017-03-31 CA CA3018192A patent/CA3018192C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017173313A1 (en) | 2017-10-05 |
| EP3436007A1 (en) | 2019-02-06 |
| EP3436007A4 (en) | 2019-10-09 |
| EP3436007B1 (en) | 2022-03-02 |
| US10889596B2 (en) | 2021-01-12 |
| JP2019510070A (ja) | 2019-04-11 |
| CA3018192A1 (en) | 2017-10-05 |
| JP6993348B2 (ja) | 2022-02-15 |
| US20190177339A1 (en) | 2019-06-13 |
| CA3018192C (en) | 2025-05-06 |
| ES2913210T3 (es) | 2022-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3289168T3 (da) | Forsegling og aktivering af borehul | |
| DK3386518T3 (da) | Metoder og sammensætninger til behandling af en serpinc1-associeret forstyrrelse | |
| DK3548033T3 (da) | Forbindelser og deres fremgangsmåde til anvendelse | |
| DK3185868T3 (da) | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme | |
| DK3494277T3 (da) | Fremgangsmåde til fjernelse af foringsrør i borehul | |
| DK3519572T3 (da) | Forbindelser og fremgangsmåder til reduktion af tau-ekspression | |
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3398022T3 (da) | Systemer og fremgangsmåder til tilpasning af uav-bane | |
| DK3701973T3 (da) | Plasmabaseret film og fremgangsmåder til fremstilling og anvendelse af samme | |
| DK3888658T3 (da) | Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil | |
| DK3245225T3 (da) | Sammensætninger og fremgangsmåder til behandling og detektering af cancere | |
| DK3242947T3 (da) | Genterapi og elektroporese til behandling af maligniteter | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3350201T3 (da) | Manipulerede fytaser og fremgangsmåder til anvendelse af samme | |
| DK4434585T3 (da) | Forbindelser og fremgangsmåder til reduktion af snca-ekspression | |
| DK3558280T3 (da) | Forebyggelse og behandling af migræne | |
| DK3353168T3 (da) | Forbindelser og fremgangsmåder til at inhibere jak | |
| DK3426777T3 (da) | Kombinationsvektorer og fremgangsmåder til behandling af cancer | |
| DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
| DK3426110T3 (da) | Samling og fremgangsmåde til opskumning af fluid | |
| DK3493812T3 (da) | Kombinationer af imetelstat og venetoclax til behandling af akut myeloid leukæmi | |
| DK3367852T3 (da) | Indretning og fremgangsmåde til behandling af levnedsmidler | |
| DK3491172T3 (da) | Fremgangsmåde og anlæg til fremstilling af methan | |
| DK3474883T3 (da) | Komplementinhibitorer og anvendelser deraf | |
| DK3472338T3 (da) | Midler og fremgangsmåder til at modifikation af flere alleler |